The Pentagon will now require annual testosterone deficiency screenings for active-duty service members aged 30 and older, a move aimed at enhancing military readiness and long-term health. The program, dubbed 'High-T,' will integrate into existing health assessments and offer voluntary testosterone replacement therapy for those diagnosed with deficiencies.
The "High-T" Initiative Unveiled
Defense Secretary Pete Hegseth announced Wednesday that the Pentagon will require annual testosterone deficiency screenings for active-duty service members aged 30 and older. The initiative, part of a broader military readiness program, will also offer optional testosterone replacement therapy for those with deficiencies. Service members under 30 can voluntarily opt for testing.
Core Facts of the New Policy
The new policy, dubbed the “High-T” initiative, will be integrated into existing periodic health assessments. Hegseth emphasized that the program is designed to restore and optimize natural capabilities, not artificially enhance performance. Treatment, if recommended, will remain voluntary.
Rationale and Goals Behind the Initiative
Hegseth framed the initiative as a way to maintain the military’s “most decisive tactical advantage” by ensuring service members operate at peak physical and mental capacity. Testosterone levels naturally decline with age, affecting muscle mass, bone density, and mental health. The Pentagon cited studies showing that roughly 2% to 50% of men experience low testosterone, with symptoms including depression, fatigue, and reduced strength.
Medical and Ethical Considerations
The Food and Drug Administration (FDA) is currently reevaluating the links between testosterone replacement therapy (TRT) and potential risks, including prostate cancer and cardiovascular issues. Some military communities, particularly special operations forces, have faced challenges with testosterone levels due to high-stress environments. Army Major Theodore Crisostomo-Wynne noted that military training can acutely or long-term decrease testosterone levels.
Policy Details and Implementation Status
The Pentagon has not yet released additional guidance on the policy’s rollout or whether it will include estrogen screenings for female service members. Hegseth stressed that the initiative is about long-term health, not just battlefield readiness, ensuring troops remain “strong, resilient, and capable” beyond their service.
Public and Political Response
The announcement comes amid broader Trump administration efforts to expand access to testosterone replacement therapies. While some advocates support the move as a proactive health measure, critics have raised concerns about the potential risks of TRT and the lack of clear guidelines for female service members.